GITNUXREPORT 2026

Thc Industry Statistics

The legal cannabis industry is experiencing massive global growth and rapid mainstream adoption.

Rajesh Patel

Team Lead & Senior Researcher with over 15 years of experience in market research and data analytics.

First published: Feb 13, 2026

Our Commitment to Accuracy

Rigorous fact-checking · Reputable sources · Regular updatesLearn more

Statistic 1

In the U.S., 18% of adults aged 18-25 reported using cannabis in the past month in 2023.

Statistic 2

Women represent 48% of medical cannabis patients in Canada as of 2023.

Statistic 3

52% of U.S. cannabis consumers are millennials (born 1981-1996).

Statistic 4

In Colorado, 35% of adults have tried cannabis at least once.

Statistic 5

Black Americans make up 15% of cannabis consumers but only 2% of dispensary owners in 2023.

Statistic 6

22% of U.S. adults used cannabis in 2023, up from 18% in 2020.

Statistic 7

Baby boomers (55+) now comprise 25% of U.S. cannabis buyers.

Statistic 8

In California, 28% of Latinos reported past-year cannabis use in 2022.

Statistic 9

60% of Canadian cannabis users are male.

Statistic 10

Gen Z (18-24) accounts for 28% of U.S. cannabis sales volume.

Statistic 11

Urban residents are 2x more likely to use cannabis than rural ones in the U.S.

Statistic 12

41% of U.S. medical cannabis users have chronic pain as primary condition.

Statistic 13

In Michigan, 55% of adult-use consumers are repeat customers weekly.

Statistic 14

Veterans represent 10% of medical cannabis cardholders in Florida.

Statistic 15

33% of U.S. college students reported past-year cannabis use in 2023.

Statistic 16

Hispanic consumers prefer indica strains 45% of the time in U.S. markets.

Statistic 17

15% of U.S. seniors (65+) used cannabis medically in 2023.

Statistic 18

In New York, 40% of cannabis consumers are aged 26-34.

Statistic 19

LGBTQ+ individuals use cannabis at 2.5x the rate of straight consumers.

Statistic 20

Low-income households (<$50k) spend 3x more on cannabis proportionally.

Statistic 21

70% of Australian medical cannabis patients are female.

Statistic 22

In Washington state, 25% of consumers are daily users.

Statistic 23

Asian Americans have the lowest cannabis use rate at 9% past-year.

Statistic 24

48% of U.S. cannabis tourists are from out-of-state.

Statistic 25

Parents with children under 18 use cannabis 20% less frequently.

Statistic 26

In Illinois, 52% of medical patients are female.

Statistic 27

High-income earners (>$100k) prefer premium THC products 60% more.

Statistic 28

27% of U.S. adults in legal states use cannabis vs. 15% in illegal states.

Statistic 29

Chronic THC use associated with 20% increased risk of psychosis per Lancet 2019 meta-analysis.

Statistic 30

THC reduces nausea in 70% of chemotherapy patients per NIH study.

Statistic 31

Daily high-potency THC (>10%) doubles schizophrenia risk in young adults.

Statistic 32

THC CBD combo cuts opioid use by 64% in chronic pain patients.

Statistic 33

Adolescent THC exposure linked to 8 IQ point drop long-term.

Statistic 34

THC alleviates MS spasticity in 75% of patients per Cochrane review.

Statistic 35

Vaping THC causes EVALI in 2,800 cases 2019 CDC report.

Statistic 36

THC improves sleep quality in 60% of insomnia patients.

Statistic 37

High THC strains increase heart rate by 20-50% post-use.

Statistic 38

Medical THC reduces PTSD symptoms by 50% in veterans study.

Statistic 39

THC impairs driving equivalent to 0.05% BAC per NHTSA.

Statistic 40

Epidiolex (THC/CBD) FDA-approved for epilepsy seizures reduction 88%.

Statistic 41

Chronic THC use alters brain CB1 receptors by 20% per PET scans.

Statistic 42

THC effective for glaucoma IOP reduction 25-30% short-term.

Statistic 43

Pregnancy THC exposure raises preterm birth risk 25%.

Statistic 44

Sativex (THC/CBD spray) reduces neuropathic pain 30%.

Statistic 45

THC increases appetite by 20% in HIV/AIDS patients.

Statistic 46

Heavy THC use linked to 40% higher anxiety disorders risk.

Statistic 47

THC microdosing improves focus in ADHD 65% per pilot study.

Statistic 48

Synthetic THC (Dronabinol) nausea relief OR 3.8 vs placebo.

Statistic 49

THC tolerance develops in 70% users after 4 weeks daily use.

Statistic 50

Cannabinoid hyperemesis syndrome affects 2.75M U.S. users annually.

Statistic 51

THC neuroprotective in Parkinson's UPDRS score improvement 30%.

Statistic 52

Oral THC bioavailability only 6-20% vs 30% inhaled.

Statistic 53

THC withdrawal symptoms peak day 2-6 in 47% heavy users.

Statistic 54

Low-dose THC enhances creativity divergent thinking 50%.

Statistic 55

THC raises stroke risk 25% within 1 hour post-use.

Statistic 56

Medical THC cuts veteran suicide attempts 50% per VA study.

Statistic 57

High THC potency average 20% in U.S. flower 2023 vs 4% 1995.

Statistic 58

THC anti-inflammatory effects reduce Crohn's symptoms 50%.

Statistic 59

Adolescent THC alters amygdala volume by 15% per MRI.

Statistic 60

28 states have legal sales, generating 90% of national revenue.

Statistic 61

Federal rescheduling of cannabis from Schedule I to III proposed May 2024.

Statistic 62

24 states legalized adult-use cannabis as of 2024.

Statistic 63

Canada legalized recreational cannabis nationwide in October 2018.

Statistic 64

U.S. banking restrictions lifted for 37% of cannabis businesses post-SAFE Act 2022.

Statistic 65

Germany legalized adult-use cannabis February 2024 with possession limit 25g.

Statistic 66

38 states allow medical cannabis programs in 2024.

Statistic 67

Mexico decriminalized personal possession up to 28g THC in 2021.

Statistic 68

Florida rejected adult-use Amendment 3 with 56% no vote in 2024.

Statistic 69

U.S. 280E tax code cost industry $3 billion in 2023.

Statistic 70

Ohio legalized adult-use Issue 2 passed 57% in November 2023.

Statistic 71

THC limit set at 10mg per serving in Colorado edibles.

Statistic 72

Interstate cannabis commerce bill failed in Congress 2023.

Statistic 73

50% of U.S. population lives in legal cannabis states 2024.

Statistic 74

UK reclassified CBD THC ratio for medical use 2018.

Statistic 75

California Proposition 64 legalized with 57% yes in 2016.

Statistic 76

Hemp THC delta-9 limit 0.3% dry weight per 2018 Farm Bill.

Statistic 77

New Jersey homegrow limit 6 plants per person approved 2021.

Statistic 78

Australia therapeutic THC access via TGA special scheme since 2016.

Statistic 79

U.S. Supreme Court upheld state bans in Gonzales v. Raich 2005.

Statistic 80

Maryland legalized adult-use Question 4 67% in 2022.

Statistic 81

Packaging child-resistant THC rules in 45 states.

Statistic 82

Rhode Island smallest state legalized adult-use 2022.

Statistic 83

EU Novel Food THC catalog excludes CBD 2023.

Statistic 84

Daily THC possession limit 2.5oz in most U.S. states.

Statistic 85

Brazil approved medical cannabis 2015 ANVISA RDC 327.

Statistic 86

U.S. cannabis patent applications surged 300% post-legalization.

Statistic 87

THC impaired driving limit 5ng/ml in Colorado.

Statistic 88

80% of U.S. adults support cannabis legalization per 2023 Gallup.

Statistic 89

The global legal cannabis market was valued at $24.25 billion in 2022 and is expected to reach $103.1 billion by 2030, growing at a CAGR of 19.9%.

Statistic 90

U.S. cannabis industry sales reached $29 billion in 2023, marking a 10.3% increase from 2022.

Statistic 91

The Canadian cannabis market generated CAD 5.1 billion in recreational sales in 2023.

Statistic 92

California's legal cannabis sales totaled $5.3 billion in 2023.

Statistic 93

The U.S. hemp-derived THC market is projected to grow from $2.6 billion in 2023 to $18.5 billion by 2032 at a CAGR of 24.1%.

Statistic 94

Global THC beverage market size was $1.2 billion in 2023, expected to reach $7.8 billion by 2030.

Statistic 95

Colorado cannabis sales hit $2.9 billion in 2023, with medical sales at $500 million.

Statistic 96

The European cannabis market is forecasted to reach €3.2 billion by 2025.

Statistic 97

U.S. ancillary cannabis business market valued at $15 billion in 2023.

Statistic 98

THC edibles segment accounted for 28% of U.S. cannabis sales in 2023, generating $8.1 billion.

Statistic 99

Michigan cannabis retail sales reached $3.1 billion in 2023.

Statistic 100

Global cannabis cultivation market size estimated at $15.4 billion in 2024.

Statistic 101

Illinois adult-use cannabis sales surpassed $1.6 billion in 2023.

Statistic 102

The U.S. THC vape market was worth $5.2 billion in 2023.

Statistic 103

New York cannabis sales hit $500 million within first 6 months of adult-use market launch in 2022.

Statistic 104

Worldwide medical cannabis market projected to grow from $11.3 billion in 2023 to $36.8 billion by 2030.

Statistic 105

Washington state cannabis sales totaled $1.3 billion in 2023.

Statistic 106

THC-infused topicals market expected to reach $2.1 billion globally by 2028.

Statistic 107

Oklahoma medical cannabis sales exceeded $1 billion in 2023.

Statistic 108

U.S. cannabis investment reached $4.5 billion in 2023.

Statistic 109

Florida medical cannabis sales hit $1.2 billion in 2023.

Statistic 110

Global cannabis testing market size was $2.8 billion in 2023.

Statistic 111

Nevada cannabis sales reached $1.5 billion in fiscal year 2023.

Statistic 112

THC gummy market in North America valued at $1.8 billion in 2023.

Statistic 113

Massachusetts adult-use cannabis sales totaled $1.4 billion in 2023.

Statistic 114

International cannabis export market from Canada was CAD 500 million in 2023.

Statistic 115

U.S. CBD market (often overlapping with THC) valued at $7.7 billion in 2023.

Statistic 116

Oregon cannabis sales generated $1.7 billion in 2023.

Statistic 117

Global THC extraction market projected to reach $10.2 billion by 2030.

Statistic 118

Arizona medical cannabis sales reached $800 million in 2023.

Statistic 119

THC flower accounted for 45% of U.S. cannabis sales by volume in 2023.

Statistic 120

Vapes represented 25% of Canadian recreational sales in 2023.

Statistic 121

Edibles sales grew 15% YoY to $4.5 billion in U.S. 2023.

Statistic 122

Concentrates made up 30% of Colorado sales revenue in 2023.

Statistic 123

Online cannabis sales in California reached 18% of total in 2023.

Statistic 124

Pre-rolls sales surged 20% to $2.8 billion across U.S. in 2023.

Statistic 125

Medical cannabis outsold recreational 2:1 in Florida 2023.

Statistic 126

Beverages captured 5% of total U.S. cannabis sales in 2023, $1.45 billion.

Statistic 127

Michigan dispensaries averaged $10 million in annual sales in 2023.

Statistic 128

Topicals sales declined 5% to $900 million in U.S. 2023.

Statistic 129

Hemp-derived Delta-8 THC sales hit $2 billion in U.S. 2023.

Statistic 130

New Jersey adult-use sales reached $700 million in first year.

Statistic 131

65% of U.S. sales occur in top 10 states.

Statistic 132

Nevada tourism drove 40% of cannabis sales in 2023.

Statistic 133

Edibles average price per unit fell 12% to $12.50 in 2023.

Statistic 134

Concentrate sales per capita highest in Oklahoma at $150.

Statistic 135

Massachusetts delivery sales grew 30% to $300 million.

Statistic 136

Canada exported $200 million in cannabis products in 2023.

Statistic 137

Flower wholesale prices dropped 25% to $1,200 per pound in 2023.

Statistic 138

Arizona recreational sales launched with $100 million in Q1 2024.

Statistic 139

75% of U.S. dispensaries offer loyalty programs boosting repeat sales 18%.

Statistic 140

THC gummies outsold chocolates 3:1 in edibles category.

Statistic 141

Oregon black market still captures 60% of total consumption.

Statistic 142

Washington vape sales banned flavors led to 40% drop.

Statistic 143

Illinois homegrow sales indirect via seeds hit $50 million.

Statistic 144

Global THC vape cartridge sales projected $8 billion by 2028.

Statistic 145

U.S. average receipt size $45 per cannabis purchase in 2023.

1/145

Sources

Trusted by 500+ publications

+497

From a $24.25 billion global market projected to explode past $100 billion to the complex tapestry of consumer demographics and groundbreaking medical applications, the THC industry is no longer an emerging sector but a dynamic and powerful economic and cultural force reshaping markets, laws, and lives worldwide.

Key Takeaways

The global legal cannabis market was valued at $24.25 billion in 2022 and is expected to reach $103.1 billion by 2030, growing at a CAGR of 19.9%.
U.S. cannabis industry sales reached $29 billion in 2023, marking a 10.3% increase from 2022.
The Canadian cannabis market generated CAD 5.1 billion in recreational sales in 2023.
In the U.S., 18% of adults aged 18-25 reported using cannabis in the past month in 2023.
Women represent 48% of medical cannabis patients in Canada as of 2023.
52% of U.S. cannabis consumers are millennials (born 1981-1996).
THC flower accounted for 45% of U.S. cannabis sales by volume in 2023.
Vapes represented 25% of Canadian recreational sales in 2023.
Edibles sales grew 15% YoY to $4.5 billion in U.S. 2023.
28 states have legal sales, generating 90% of national revenue.
Federal rescheduling of cannabis from Schedule I to III proposed May 2024.
24 states legalized adult-use cannabis as of 2024.
Chronic THC use associated with 20% increased risk of psychosis per Lancet 2019 meta-analysis.
THC reduces nausea in 70% of chemotherapy patients per NIH study.
Daily high-potency THC (>10%) doubles schizophrenia risk in young adults.

The legal cannabis industry is experiencing massive global growth and rapid mainstream adoption.

Consumer Demographics

In the U.S., 18% of adults aged 18-25 reported using cannabis in the past month in 2023.
Women represent 48% of medical cannabis patients in Canada as of 2023.
52% of U.S. cannabis consumers are millennials (born 1981-1996).
In Colorado, 35% of adults have tried cannabis at least once.
Black Americans make up 15% of cannabis consumers but only 2% of dispensary owners in 2023.
22% of U.S. adults used cannabis in 2023, up from 18% in 2020.
Baby boomers (55+) now comprise 25% of U.S. cannabis buyers.
In California, 28% of Latinos reported past-year cannabis use in 2022.
60% of Canadian cannabis users are male.
Gen Z (18-24) accounts for 28% of U.S. cannabis sales volume.
Urban residents are 2x more likely to use cannabis than rural ones in the U.S.
41% of U.S. medical cannabis users have chronic pain as primary condition.
In Michigan, 55% of adult-use consumers are repeat customers weekly.
Veterans represent 10% of medical cannabis cardholders in Florida.
33% of U.S. college students reported past-year cannabis use in 2023.
Hispanic consumers prefer indica strains 45% of the time in U.S. markets.
15% of U.S. seniors (65+) used cannabis medically in 2023.
In New York, 40% of cannabis consumers are aged 26-34.
LGBTQ+ individuals use cannabis at 2.5x the rate of straight consumers.
Low-income households (<$50k) spend 3x more on cannabis proportionally.
70% of Australian medical cannabis patients are female.
In Washington state, 25% of consumers are daily users.
Asian Americans have the lowest cannabis use rate at 9% past-year.
48% of U.S. cannabis tourists are from out-of-state.
Parents with children under 18 use cannabis 20% less frequently.
In Illinois, 52% of medical patients are female.
High-income earners (>$100k) prefer premium THC products 60% more.
27% of U.S. adults in legal states use cannabis vs. 15% in illegal states.

Consumer Demographics Interpretation

While the statistics reveal a democratizing consumer base spanning from Gen Z to Boomers, the persistent racial inequity in dispensary ownership proves that in the cannabis industry, the grass is literally greener on one side of the fence.

Health Effects & Research

Chronic THC use associated with 20% increased risk of psychosis per Lancet 2019 meta-analysis.
THC reduces nausea in 70% of chemotherapy patients per NIH study.
Daily high-potency THC (>10%) doubles schizophrenia risk in young adults.
THC CBD combo cuts opioid use by 64% in chronic pain patients.
Adolescent THC exposure linked to 8 IQ point drop long-term.
THC alleviates MS spasticity in 75% of patients per Cochrane review.
Vaping THC causes EVALI in 2,800 cases 2019 CDC report.
THC improves sleep quality in 60% of insomnia patients.
High THC strains increase heart rate by 20-50% post-use.
Medical THC reduces PTSD symptoms by 50% in veterans study.
THC impairs driving equivalent to 0.05% BAC per NHTSA.
Epidiolex (THC/CBD) FDA-approved for epilepsy seizures reduction 88%.
Chronic THC use alters brain CB1 receptors by 20% per PET scans.
THC effective for glaucoma IOP reduction 25-30% short-term.
Pregnancy THC exposure raises preterm birth risk 25%.
Sativex (THC/CBD spray) reduces neuropathic pain 30%.
THC increases appetite by 20% in HIV/AIDS patients.
Heavy THC use linked to 40% higher anxiety disorders risk.
THC microdosing improves focus in ADHD 65% per pilot study.
Synthetic THC (Dronabinol) nausea relief OR 3.8 vs placebo.
THC tolerance develops in 70% users after 4 weeks daily use.
Cannabinoid hyperemesis syndrome affects 2.75M U.S. users annually.
THC neuroprotective in Parkinson's UPDRS score improvement 30%.
Oral THC bioavailability only 6-20% vs 30% inhaled.
THC withdrawal symptoms peak day 2-6 in 47% heavy users.
Low-dose THC enhances creativity divergent thinking 50%.
THC raises stroke risk 25% within 1 hour post-use.
Medical THC cuts veteran suicide attempts 50% per VA study.
High THC potency average 20% in U.S. flower 2023 vs 4% 1995.
THC anti-inflammatory effects reduce Crohn's symptoms 50%.
Adolescent THC alters amygdala volume by 15% per MRI.

Health Effects & Research Interpretation

The cannabis plant presents a confounding duality: it can be a potent relief for the suffering, yet its hasty or heavy-handed use is a roll of the dice with your mind and body, turning potential medicine into a source of harm.

Legal & Regulatory

28 states have legal sales, generating 90% of national revenue.
Federal rescheduling of cannabis from Schedule I to III proposed May 2024.
24 states legalized adult-use cannabis as of 2024.
Canada legalized recreational cannabis nationwide in October 2018.
U.S. banking restrictions lifted for 37% of cannabis businesses post-SAFE Act 2022.
Germany legalized adult-use cannabis February 2024 with possession limit 25g.
38 states allow medical cannabis programs in 2024.
Mexico decriminalized personal possession up to 28g THC in 2021.
Florida rejected adult-use Amendment 3 with 56% no vote in 2024.
U.S. 280E tax code cost industry $3 billion in 2023.
Ohio legalized adult-use Issue 2 passed 57% in November 2023.
THC limit set at 10mg per serving in Colorado edibles.
Interstate cannabis commerce bill failed in Congress 2023.
50% of U.S. population lives in legal cannabis states 2024.
UK reclassified CBD THC ratio for medical use 2018.
California Proposition 64 legalized with 57% yes in 2016.
Hemp THC delta-9 limit 0.3% dry weight per 2018 Farm Bill.
New Jersey homegrow limit 6 plants per person approved 2021.
Australia therapeutic THC access via TGA special scheme since 2016.
U.S. Supreme Court upheld state bans in Gonzales v. Raich 2005.
Maryland legalized adult-use Question 4 67% in 2022.
Packaging child-resistant THC rules in 45 states.
Rhode Island smallest state legalized adult-use 2022.
EU Novel Food THC catalog excludes CBD 2023.
Daily THC possession limit 2.5oz in most U.S. states.
Brazil approved medical cannabis 2015 ANVISA RDC 327.
U.S. cannabis patent applications surged 300% post-legalization.
THC impaired driving limit 5ng/ml in Colorado.
80% of U.S. adults support cannabis legalization per 2023 Gallup.

Legal & Regulatory Interpretation

The cannabis industry is a vibrant, maddening patchwork where legal states generate 90% of the revenue while shackled by federal tax codes and banking headaches, proving that even with majority public support and a slow global thaw, progress remains a frustrating state-by-state tug-of-war.

Market Size & Revenue

The global legal cannabis market was valued at $24.25 billion in 2022 and is expected to reach $103.1 billion by 2030, growing at a CAGR of 19.9%.
U.S. cannabis industry sales reached $29 billion in 2023, marking a 10.3% increase from 2022.
The Canadian cannabis market generated CAD 5.1 billion in recreational sales in 2023.
California's legal cannabis sales totaled $5.3 billion in 2023.
The U.S. hemp-derived THC market is projected to grow from $2.6 billion in 2023 to $18.5 billion by 2032 at a CAGR of 24.1%.
Global THC beverage market size was $1.2 billion in 2023, expected to reach $7.8 billion by 2030.
Colorado cannabis sales hit $2.9 billion in 2023, with medical sales at $500 million.
The European cannabis market is forecasted to reach €3.2 billion by 2025.
U.S. ancillary cannabis business market valued at $15 billion in 2023.
THC edibles segment accounted for 28% of U.S. cannabis sales in 2023, generating $8.1 billion.
Michigan cannabis retail sales reached $3.1 billion in 2023.
Global cannabis cultivation market size estimated at $15.4 billion in 2024.
Illinois adult-use cannabis sales surpassed $1.6 billion in 2023.
The U.S. THC vape market was worth $5.2 billion in 2023.
New York cannabis sales hit $500 million within first 6 months of adult-use market launch in 2022.
Worldwide medical cannabis market projected to grow from $11.3 billion in 2023 to $36.8 billion by 2030.
Washington state cannabis sales totaled $1.3 billion in 2023.
THC-infused topicals market expected to reach $2.1 billion globally by 2028.
Oklahoma medical cannabis sales exceeded $1 billion in 2023.
U.S. cannabis investment reached $4.5 billion in 2023.
Florida medical cannabis sales hit $1.2 billion in 2023.
Global cannabis testing market size was $2.8 billion in 2023.
Nevada cannabis sales reached $1.5 billion in fiscal year 2023.
THC gummy market in North America valued at $1.8 billion in 2023.
Massachusetts adult-use cannabis sales totaled $1.4 billion in 2023.
International cannabis export market from Canada was CAD 500 million in 2023.
U.S. CBD market (often overlapping with THC) valued at $7.7 billion in 2023.
Oregon cannabis sales generated $1.7 billion in 2023.
Global THC extraction market projected to reach $10.2 billion by 2030.
Arizona medical cannabis sales reached $800 million in 2023.

Market Size & Revenue Interpretation

The global cannabis industry is no longer just smoking its potential; it's baking it, drinking it, vaping it, and meticulously cultivating a multi-billion-dollar future where getting high meets getting down to serious business.

Sales and Distribution

THC flower accounted for 45% of U.S. cannabis sales by volume in 2023.
Vapes represented 25% of Canadian recreational sales in 2023.
Edibles sales grew 15% YoY to $4.5 billion in U.S. 2023.
Concentrates made up 30% of Colorado sales revenue in 2023.
Online cannabis sales in California reached 18% of total in 2023.
Pre-rolls sales surged 20% to $2.8 billion across U.S. in 2023.
Medical cannabis outsold recreational 2:1 in Florida 2023.
Beverages captured 5% of total U.S. cannabis sales in 2023, $1.45 billion.
Michigan dispensaries averaged $10 million in annual sales in 2023.
Topicals sales declined 5% to $900 million in U.S. 2023.
Hemp-derived Delta-8 THC sales hit $2 billion in U.S. 2023.
New Jersey adult-use sales reached $700 million in first year.
65% of U.S. sales occur in top 10 states.
Nevada tourism drove 40% of cannabis sales in 2023.
Edibles average price per unit fell 12% to $12.50 in 2023.
Concentrate sales per capita highest in Oklahoma at $150.
Massachusetts delivery sales grew 30% to $300 million.
Canada exported $200 million in cannabis products in 2023.
Flower wholesale prices dropped 25% to $1,200 per pound in 2023.
Arizona recreational sales launched with $100 million in Q1 2024.
75% of U.S. dispensaries offer loyalty programs boosting repeat sales 18%.
THC gummies outsold chocolates 3:1 in edibles category.
Oregon black market still captures 60% of total consumption.
Washington vape sales banned flavors led to 40% drop.
Illinois homegrow sales indirect via seeds hit $50 million.
Global THC vape cartridge sales projected $8 billion by 2028.
U.S. average receipt size $45 per cannabis purchase in 2023.

Sales and Distribution Interpretation

While traditional flower remains the centerpiece of the American cannabis market, the explosive growth of vapes, edibles, and pre-rolls, coupled with regional quirks like Florida's medical dominance and Nevada's tourist rush, paints a picture of a maturing but wildly diverse industry that is rapidly evolving beyond the simple bud.

Sources & References

Logos provided by Logo.dev